Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF3C2 antisense RNA 1 (GTF3C2-AS1) is a long non-coding RNA gene located on chromosome 2, functioning as an antisense transcript to the General Transcription Factor IIIC Subunit 2 (GTF3C2). Non-coding RNAs like GTF3C2-AS1 do not produce proteins but modulate gene expression, often by interacting with protein complexes or through epigenetic regulation. GTF3C2-AS1 has been implicated in transcriptional regulation, cell growth, and proliferation. Recent studies identify GTF3C2-AS1 as a member of prognostic lncRNA panels capable of stratifying endometrial cancer patients by survival risk, making it a potential molecular marker for cancer prognosis. However, its specific biological roles and mechanisms remain under-researched, with no direct evidence for use as a therapeutic target or known drug interactions. GTF3C2-AS1 stands as a candidate biomarker and regulatory molecule within cancer biology, with further research needed to fully elucidate its contributions to gene regulation and disease
None defined. No mechanisms of action for drugs against GTF3C2-AS1, as it is not currently a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTF3C2 antisense RNA 1 (GTF3C2-AS1).